Global Rapid Microbiology Testing Market

Rapid Microbiology Testing Market Size, Share, Growth Analysis, By Product(Instruments, Reagents and Kits, and Consumables), By Application(Clinical Disease Diagnosis, Food and Beverage Testing, Pharmaceutical and Biological Drug Testing, Environmental Testing), By End-User(Laboratories & Hospitals, Pharmaceuticals and Biotechnology Companies, Contract Research Organizations, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2782 | Region: Global | Published Date: April, 2024
Pages: 219 |Tables: 95 |Figures: 70

Rapid Microbiology Testing Market Insights

Global Rapid Microbiology Testing Market size was valued at USD 4.20 billion in 2022 and is poised to grow from USD 4.59 billion in 2023 to USD 9.43 billion by 2031, growing at a CAGR of 5.80% during the forecast period (2024-2031).

The rapid microbiology testing market is witnessing significant growth, propelled by a confluence of crucial factors. Chief among these is the escalating concern regarding food safety, driving the demand for reliable testing methods. Technological advancements, alongside increased funding, research grants, and public-private investments, further amplify the market's expansion. The rising adoption of microbiology testing for diagnosing infectious diseases in humans is a noteworthy trend, emphasizing the importance of effective and early disease detection. The surge in research activities, coupled with an increasing incidence of infectious diseases and continuous technological innovations, contributes to the market's rapid evolution.

Additionally, the heightened emphasis on detecting antimicrobial resistance through government initiatives, particularly in emerging countries, adds a layer of opportunity to the market landscape. The global focus on bioterrorism surveillance is another catalyst, fostering new prospects for the rapid microbiology testing market in the forecasted period. This multifaceted growth trajectory reflects a dynamic interplay of diverse factors, positioning the market as a critical player in addressing food safety concerns, infectious diseases, and advancing diagnostic capabilities on a global scale.

Market Snapshot - 2024-2031

Global Market Size

USD 4.20 billion

Largest Segment

Reagents and Kits

Fastest Growth

Growth Rate

5.80% CAGR

Global Rapid Microbiology Testing Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Rapid Microbiology Testing Market Segmental Analysis

Based on Product, the market is segmented into Instruments, Reagents and Kits, and Consumables. Based on Application, the market has been segmented into Clinical Disease Diagnosis, Food and Beverage Testing, Pharmaceutical and Biological Drug Testing, Environmental Testing, Cosmetics and Personal Care Products Testing, Research Applications, and Others. By End-User, the market is divided into Laboratories & Hospitals, Pharmaceuticals and Biotechnology Companies, Contract Research Organizations, and Others. Based on Region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

Analysis by Product

The instruments segment has emerged as the dominant force in the rapid microbiology testing market, capturing the largest share. This supremacy can be attributed to a combination of factors driving growth within this segment. Increased investments in research and development (R&D) have propelled the innovation and sophistication of microbiology testing instruments, enhancing their capabilities and efficiency. The growing incidence of infectious diseases and cancer has further intensified the demand for rapid and reliable testing methods, with instruments playing a pivotal role in diagnostic processes.

The reagents and kits segment plays a fundamental role in propelling the growth and efficiency of the rapid microbiology testing market. This segment encompasses a range of essential components, including reagents, assay kits, and consumables designed for swift and accurate microbial analysis. These reagents and kits form the backbone of various diagnostic procedures, enabling the identification and quantification of microorganisms in diverse samples. The convenience and reliability offered by these ready-to-use solutions make them integral for laboratories and diagnostic facilities.

Analysis by Application

The clinical disease diagnostics segment has emerged as the predominant contributor, claiming the largest share in the rapid microbiology testing market. The unparalleled growth of this segment is primarily propelled by the escalating incidence of infectious diseases and cancer. As these health challenges continue to surge globally, there is an increasing demand for rapid and accurate diagnostic solutions, positioning clinical disease diagnostics at the forefront. The imperative for swift and precise disease identification, especially in the case of infectious diseases and cancer, has accentuated the significance of this segment.

The environmental testing segment plays a pivotal role in the rapid microbiology testing market, addressing critical aspects of public health and safety. This segment is dedicated to assessing and monitoring microbial contamination in various environmental settings, including air, water, and surfaces. By employing rapid microbiology testing methods, environmental testing ensures the timely detection of potential threats such as harmful pathogens and contaminants.

Global Rapid Microbiology Testing Market By Product, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Rapid Microbiology Testing Market Regional Insights

North America has emerged as the frontrunner, accounting for the largest share in the global market. The robust growth in the market is underpinned by multiple factors, including heightened government initiatives aimed at advancing healthcare development within the region. There is also a growing emphasis on raising awareness regarding the early detection of infectious diseases, which has contributed significantly to the market's expansion.

The Asia Pacific is poised for substantial expansion in the coming years, driven by several impactful factors. The escalating demand for food safety testing stands out as a primary catalyst, reflecting the region's growing emphasis on ensuring the quality and safety of consumables. Additionally, the rising incidence of infectious diseases has heightened the need for advanced microbiology testing methods, further stimulating market growth.

Global Rapid Microbiology Testing Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Rapid Microbiology Testing Market Dynamics

Drivers

Increasing Incidence of Infectious Disease and Growing Outbreaks of Epidemics

  • The rising incidence of infectious diseases and the emergence of global epidemics and pandemics, such as Pneumonia have led to a substantial uptick in the utilization of diagnostic tests. The surge in the global burden of these diseases has heightened public awareness, fostering a growing emphasis on early disease detection. Recognizing the critical role of diagnostic tests in identifying and managing infectious diseases, there is an increasing demand for these diagnostic tools. This heightened awareness, coupled with a proactive approach towards timely disease detection, is anticipated to drive significant growth in the diagnostic testing sector during the forecast period.

Restraints

High Capital Investments

  • The development of diagnostic tests, particularly those tailored for cancer and infectious diseases, necessitates substantial capital investment, primarily to meet rigorous regulatory requirements. The evolving landscape of diagnostic technologies and the increasing stringency of regulatory guidelines demand extensive financial resources for each phase of clinical trials. The heightened regulatory scrutiny and the need to comply with stringent standards create interruptions in the development process, translating to a requirement for heavy investments to navigate the complexities of clinical trials and secure regulatory approvals.

Request Free Customization of this report to help us to meet your business objectives.

Rapid Microbiology Testing Market Competitive Landscape

The competitive environment of the global Rapid Microbiology Testing market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.

Top Player’s Company Profiles

  • Abbott Laboratories, Inc. (US)
  • Thermo Fisher Scientific (US)
  • Biomerieux SA (France)
  • Becton, Dickinson, and Company (US)
  • Danaher Corporation (US)
  • Merck KGaA (Germany)
  • NEOGEN Corporation (US)
  • Quidel Corporation (US)
  • Sartorius AG (Germany)
  • Thermo Fisher Scientific Inc. (US)
  • Don Whitley Scientific Limited (UK)
  • Rapid Micro Biosystems Inc. (US)
  • Vivione Biosciences LLC (US)
  • Mocon, Inc (US)

Recent Developments

  • In November 2022, IDEXX made a strategic acquisition by adding Tecta-PDS, a pioneering Canadian company, to its portfolio. Tecta-PDS is recognized for introducing automation to water microbiology testing, specifically for critical parameters such as E. coli and total coliforms. This acquisition has significantly enhanced IDEXX's capabilities in water microbiology testing, offering a broader spectrum of options for both laboratory-based and in-field testing. The move underscores IDEXX's commitment to innovation and diversification in the diagnostic testing landscape, particularly in the crucial domain of water safety.
  • In November 2022, Archer Daniels Midland (ADM) marked a notable development by inaugurating a new microbiology laboratory at its ADM Specialty Manufacturing facility in Decatur, Illinois. This strategic initiative resulted in the doubling of the site's microbiology laboratory footprint and a substantial expansion of its testing capabilities. The enhanced laboratory infrastructure positions ADM to strengthen its quality control measures and advance its capabilities in microbiological testing. This expansion aligns with ADM's commitment to maintaining high standards in its manufacturing processes and underscores the company's dedication to fostering innovation and quality assurance within the realm of microbiology testing. Both IDEXX and ADM's initiatives in November 2022 highlight the ongoing advancements and investments in microbiology testing across various industries.

Rapid Microbiology Testing Key Market Trends

  • Promising avenues for growth are evident in emerging economies such as India, South Korea, Brazil, and Mexico, presenting substantial opportunities for market players. Several factors contribute to the attractiveness of these markets, including a high prevalence of diseases, a sizable patient population, ongoing improvements in healthcare infrastructure, rising disposable income levels, and a burgeoning trend of medical tourism. The prevalence of diseases in these regions underscores the demand for advanced healthcare solutions, including diagnostic and therapeutic interventions. The continual enhancement of healthcare infrastructure further facilitates the adoption of innovative medical technologies.

Rapid Microbiology Testing Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The rising prevalence of severe and potentially fatal sexually transmitted diseases (STDs) such as HIV, human papillomavirus (HPV), and hepatitis B and C is contributing to an increased demand for microbiology testing. These infectious diseases carry significant health risks and necessitate accurate and timely diagnostic measures. Notably, human papillomavirus (HPV) has emerged as one of the most commonly encountered sexually transmitted infections, as highlighted in an article published by the virology journal in September 2022. HPV is known to be a causative factor in the development of various cancers, including cervical, vaginal, vulvar, anal, penile, and oropharyngeal cancers. The severity of these diseases underscores the critical need for effective microbiology testing to facilitate early detection, diagnosis, and subsequent intervention. As the incidence of these STDs continues to rise, the microbiology testing market plays a pivotal role in supporting public health efforts to mitigate the impact of these infectious diseases and improve overall patient outcomes.

Report Metric Details
Market size value in 2023 USD 4.20 billion
Market size value in 2031 USD 9.43 billion
Growth Rate 5.80%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Instruments, Reagents and Kits, and Consumables
  • Application
    • Clinical Disease Diagnosis, Food and Beverage Testing, Pharmaceutical and Biological Drug Testing, Environmental Testing, Cosmetics and Personal Care Products Testing, Research Applications, and Others
  • End-User
    • Laboratories & Hospitals, Pharmaceuticals and Biotechnology Companies, Contract Research Organizations, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories, Inc. (US)
  • Thermo Fisher Scientific (US)
  • Biomerieux SA (France)
  • Becton, Dickinson, and Company (US)
  • Danaher Corporation (US)
  • Merck KGaA (Germany)
  • NEOGEN Corporation (US)
  • Quidel Corporation (US)
  • Sartorius AG (Germany)
  • Thermo Fisher Scientific Inc. (US)
  • Don Whitley Scientific Limited (UK)
  • Rapid Micro Biosystems Inc. (US)
  • Vivione Biosciences LLC (US)
  • Mocon, Inc (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Rapid Microbiology Testing Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Rapid Microbiology Testing Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Rapid Microbiology Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Rapid Microbiology Testing Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Rapid Microbiology Testing Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Rapid Microbiology Testing Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Rapid Microbiology Testing Market size was valued at USD 4.20 billion in 2022 and is poised to grow from USD 4.59 billion in 2023 to USD 9.43 billion by 2031, growing at a CAGR of 5.80% during the forecast period (2024-2031).

The competitive environment of the Rapid Microbiology Testing market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 'Abbott Laboratories, Inc. (US)', 'Thermo Fisher Scientific (US)', 'Biomerieux SA (France)', 'Becton, Dickinson, and Company (US)', 'Danaher Corporation (US)', 'Merck KGaA (Germany)', 'NEOGEN Corporation (US)', 'Quidel Corporation (US)', 'Sartorius AG (Germany)', 'Thermo Fisher Scientific Inc. (US)', 'Don Whitley Scientific Limited (UK)', 'Rapid Micro Biosystems Inc. (US)', 'Vivione Biosciences LLC (US)', 'Mocon, Inc (US)'

The rising incidence of infectious diseases and the emergence of epidemics and pandemics, such as Pneumonia have led to a substantial uptick in the utilization of diagnostic tests. The surge in the burden of these diseases has heightened public awareness, fostering a growing emphasis on early disease detection. Recognizing the critical role of diagnostic tests in identifying and managing infectious diseases, there is an increasing demand for these diagnostic tools. This heightened awareness, coupled with a proactive approach towards timely disease detection, is anticipated to drive significant growth in the diagnostic testing sector during the forecast period.

Promising avenues for growth are evident in emerging economies such as India, South Korea, Brazil, and Mexico, presenting substantial opportunities for market players. Several factors contribute to the attractiveness of these markets, including a high prevalence of diseases, a sizable patient population, ongoing improvements in healthcare infrastructure, rising disposable income levels, and a burgeoning trend of medical tourism. The prevalence of diseases in these regions underscores the demand for advanced healthcare solutions, including diagnostic and therapeutic interventions. The continual enhancement of healthcare infrastructure further facilitates the adoption of innovative medical technologies.

North America has emerged as the frontrunner, accounting for the largest share in the market. The robust growth in the market is underpinned by multiple factors, including heightened government initiatives aimed at advancing healthcare development within the region. There is also a growing emphasis on raising awareness regarding the early detection of infectious diseases, which has contributed significantly to the market's expansion.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Rapid Microbiology Testing Market

Product ID: SQMIG35A2782

$5,300
BUY NOW GET FREE SAMPLE